No | Service |
| Total | MMT patient | ART patient | PWID | FSW | MSM | p |
| Sample Size | N | 2380 | 686 | 674 | 653 | 168 | 199 |
|
1 | NSP | 672 | 528 (78.6%) | 134 (62.6%) | 49 (51.0%) | 337 (96.3%) | 4 (50%) | 4 (100%) | a |
2 | CLP | 1225 | 1018 (83.1%) | 286 (71.9%) | 203 (79.6%) | 240 (92.2%) | 141 (92.7%) | 148 (87.1%) | a |
3 | MMT | 1170 | 1124 (96.1%) | 667 (97.2%) | 76 (89.4%) | 360 (95.5%) | 10 (90.9%) | 11 (100%) | b |
4 | IEC | 1777 | 1608 (90.5%) | 475 (89.6%) | 404 (90.2%) | 432 (94.7%) | 141 (88.1%) | 156 (85.2%) | b |
5 | HTC | 1957 | 1878 (96.0%) | 568 (95.6%) | 444 (95.5%) | 557 (97.0%) | 133 (94.3%) | 176 (96.2%) |
|
6 | PMTCT | 130 | 123 (94.6%) | 5 (100%) | 54 (91.5%) | 11/11 (100%) | 53 (96.4%) | - |
|
7 | ART | 910 | 896 (98.5%) | 84 (95.5%) | 665 (98.7%) | 85 (98.8%) | 12 (100%) | 50 (100%) |
|
8 | TB/HIV Treatment | 182 | 169 (92.9%) | 30 (88.2) | 118 (95.2%) | 5 (100%) | - | 16 (84.2%) |
|
9 | OI Treatment/Prevention | 115 | 111 (96.5%) | 31 (100%) | 64 (94.1%) | 8 (100%) | - | 8 (100%) |
|